2023, 13 September
Quinten Health at BiotechX Europe 2023 for the sec...
Quinten Health will be at BioTechX Europe in Basel, Switzerland.For the second year running, Quinten Health will be present at BioTechX! It's an...
2023, 06 July
Machine learning algorithm identifies undiagnosed ...
Experts at Quinten Health have developed a supervised machine learning algorithm to identify undiagnosed episodes of pertussis in adolescents and...
2023, 29 June
Developing a machine learning algorithm to detect ...
Quinten Health has developed a machine learning algorithm to identify misdiagnosed or undiagnosed episodes of whooping cough in patients...
2023, 20 June
Quinten Health’s poster selected for presentatio...
Quinten Health's team presented their poster “Artificial intelligence for real-life disease modeling: vision, examples and impact on drug...
2023, 17 May
Machine Learning (ML) applied to real-world data t...
Newly diagnosed metastatic melanoma patients are often treated with molecular targeted therapy (TT) or with immunotherapy (IO).
2023, 19 April
“Securing & accelerating clinical developme...
Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table...
2022, 02 November
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland.Alexandre Templier (President and co-founder) and Frank Ahrens...